These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8698504)

  • 21. IgG antibody subclass responses determined by immunoblot in infants' sera following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine.
    Martin S; Sadler F; Borrow R; Dawson M; Fox A; Cartwright K
    Vaccine; 2001 Aug; 19(31):4404-8. PubMed ID: 11483265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial.
    Marsay L; Dold C; Green CA; Rollier CS; Norheim G; Sadarangani M; Shanyinde M; Brehony C; Thompson AJ; Sanders H; Chan H; Haworth K; Derrick JP; Feavers IM; Maiden MC; Pollard AJ
    J Infect; 2015 Sep; 71(3):326-37. PubMed ID: 25982025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.
    Marzoa J; Sánchez S; Costoya L; Diéguez-Casal E; Freixeiro P; Brookes C; Allen L; Taylor S; Gorringe AR; Ferreirós CM; Criado MT
    Vaccine; 2012 Mar; 30(13):2387-95. PubMed ID: 21911024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine.
    Claassen I; Meylis J; van der Ley P; Peeters C; Brons H; Robert J; Borsboom D; van der Ark A; van Straaten I; Roholl P; Kuipers B; Poolman J
    Vaccine; 1996 Jul; 14(10):1001-8. PubMed ID: 8873395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide.
    van den Elsen JM; Herron JN; Hoogerhout P; Poolman JT; Boel E; Logtenberg T; Wilting J; Crommelin DJ; Kroon J; Gros P
    Proteins; 1997 Sep; 29(1):113-25. PubMed ID: 9294871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice.
    Peeters CC; Claassen IJ; Schuller M; Kersten GF; van der Voort EM; Poolman JT
    Vaccine; 1999 Jun; 17(20-21):2702-12. PubMed ID: 10418921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and immunologic characterization of a novel serotype 4, 15 strain of Neisseria meningitidis.
    Bash MC; Lynn F; Concepcion NF; Tappero JW; Carlone GM; Frasch CE
    FEMS Immunol Med Microbiol; 2000 Nov; 29(3):169-76. PubMed ID: 11064262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB.
    Lehmann AK; Halstensen A; Aaberge IS; Holst J; Michaelsen TE; Sornes S; Wetzler LM; Guttormsen H
    Infect Immun; 1999 May; 67(5):2552-60. PubMed ID: 10225920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.
    Rosenqvist E; Musacchio A; Aase A; Høiby EA; Namork E; Kolberg J; Wedege E; Delvig A; Dalseg R; Michaelsen TE; Tommassen J
    Infect Immun; 1999 Mar; 67(3):1267-76. PubMed ID: 10024570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys.
    Rouppe van der Voort E; Schuller M; Holst J; de Vries P; van der Ley P; van den Dobbelsteen G; Poolman J
    Vaccine; 2000 Jan; 18(14):1334-43. PubMed ID: 10618530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains.
    Moe GR; Zuno-Mitchell P; Hammond SN; Granoff DM
    Infect Immun; 2002 Nov; 70(11):6021-31. PubMed ID: 12379678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.
    Cartwright K; Morris R; Rümke H; Fox A; Borrow R; Begg N; Richmond P; Poolman J
    Vaccine; 1999 Jun; 17(20-21):2612-9. PubMed ID: 10418910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of in vitro folded outer membrane protein PorA of Neisseria meningitidis.
    Jansen C; Kuipers B; van der Biezen J; de Cock H; van der Ley P; Tommassen J
    FEMS Immunol Med Microbiol; 2000 Mar; 27(3):227-33. PubMed ID: 10683467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression.
    Keiser PB; Biggs-Cicatelli S; Moran EE; Schmiel DH; Pinto VB; Burden RE; Miller LB; Moon JE; Bowden RA; Cummings JF; Zollinger WD
    Vaccine; 2011 Feb; 29(7):1413-20. PubMed ID: 21199704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PorA-specific differences in antibody avidity after vaccination with a hexavalent Men B outer membrane vesicle vaccine in toddlers and school children.
    Vermont CL; Van Dijken HH; De Groot R; Van Alphen L; Van Den Dobbelsteen GP
    Vaccine; 2004 Aug; 22(23-24):3008-13. PubMed ID: 15297049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide.
    Christodoulides M; McGuinness BT; Heckels JE
    J Gen Microbiol; 1993 Aug; 139(8):1729-38. PubMed ID: 7691983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease.
    Idänpään-Heikkilä I; Høiby EA; Chattopadhyay P; Airaksinen U; Michaelsen TM; Wedege E
    J Med Microbiol; 1995 Nov; 43(5):335-43. PubMed ID: 7562997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis.
    Humphries HE; Williams JN; Blackstone R; Jolley KA; Yuen HM; Christodoulides M; Heckels JE
    Vaccine; 2006 Jan; 24(1):36-44. PubMed ID: 16105711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci.
    Christodoulides M; Brooks JL; Rattue E; Heckels JE
    Microbiology (Reading); 1998 Nov; 144 ( Pt 11)():3027-3037. PubMed ID: 9846738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread.
    Jelfs J; Munro R; Wedege E; Caugant DA
    Clin Diagn Lab Immunol; 2000 May; 7(3):390-5. PubMed ID: 10799451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.